Centre for Depression and Suicide Studies, Unity Health Toronto, Toronto, ON, Canada; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
J Affect Disord. 2024 Apr 15;351:631-640. doi: 10.1016/j.jad.2024.01.246. Epub 2024 Jan 28.
We examine structural brain characteristics across three diagnostic categories: at risk for serious mental illness; first-presenting episode and recurrent major depressive disorder (MDD). We investigate whether the three diagnostic groups display a stepwise pattern of brain changes in the cortico-limbic regions. Integrated clinical and neuroimaging data from three large Canadian studies were pooled (total n = 622 participants, aged 12-66 years). Four clinical profiles were used in the classification of a clinical staging model: healthy comparison individuals with no history of depression (HC, n = 240), individuals at high risk for serious mental illness due to the presence of subclinical symptoms (SC, n = 80), first-episode depression (FD, n = 82), and participants with recurrent MDD in a current major depressive episode (RD, n = 220). Whole-brain volumetric measurements were extracted with FreeSurfer 7.1 and examined using three different types of analyses. Hippocampal volume decrease and cortico-limbic thinning were the most informative features for the RD vs HC comparisons. FD vs HC revealed that FD participants were characterized by a focal decrease in cortical thickness and global enlargement in amygdala volumes. Greater total amygdala volumes were significantly associated with earlier onset of illness in the FD but not the RD group. We did not confirm the construct validity of a tested clinical staging model, as a differential pattern of brain alterations was identified across the three diagnostic groups that did not parallel a stepwise clinical staging approach. The pathological processes during early stages of the illness may fundamentally differ from those that occur at later stages with clinical progression.
有严重精神疾病风险的人群;首发发作和复发性重度抑郁症(MDD)患者。我们调查了这三个诊断组在皮质边缘区域是否存在逐步的大脑变化模式。综合了来自三个加拿大大型研究的临床和神经影像学数据(总 n=622 名参与者,年龄 12-66 岁)。在临床分期模型的分类中使用了四个临床特征:没有抑郁史的健康对照组个体(HC,n=240)、存在亚临床症状的严重精神疾病高风险个体(SC,n=80)、首发抑郁症(FD,n=82)和当前重性抑郁发作中复发性 MDD 患者(RD,n=220)。使用 FreeSurfer 7.1 提取全脑体积测量值,并使用三种不同类型的分析进行检查。海马体积减少和皮质边缘变薄是 RD 与 HC 比较最具信息性的特征。FD 与 HC 相比,FD 参与者的特征是皮质厚度局部减少,杏仁核体积全面增大。总杏仁核体积越大,FD 组的发病年龄越早,但 RD 组则不然。我们没有证实所测试的临床分期模型的结构有效性,因为在三个诊断组中发现了不同的大脑改变模式,与逐步的临床分期方法并不一致。在疾病的早期阶段,病理过程可能与临床进展后的阶段根本不同。